Residency · Birmingham, AL
Sponsored by University of Alabama Hospital
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 1,452 citations · Darryl Outlaw
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma.
The New England journal of medicine · 2025 · 482 citations · Charles Cowey
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 1,863 citations · Monalisa Ghosh
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.
Lancet (London, England) · 2024 · 686 citations · Charles Cowey
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.
JAMA · 2023 · 730 citations · Nathan Erdmann
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
The New England journal of medicine · 2021 · 1,404 citations · Nathan Erdmann
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 981 citations · Charles Cowey
Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 501 citations · Darryl Outlaw